Briacell Therapeutics Corp
General ticker "BCTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.3M
Briacell Therapeutics Corp does not follow the US Stock Market performance with the rate: -40.4%.
Estimated limits based on current volatility of 4.7%: low 0.56$, high 0.62$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Current price 19.2% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-07-31 to 2026-07-31
- 2024-07-31 to 2025-07-31 estimated range: [0.65$, 2.04$]
- 2025-07-31 to 2026-07-31 estimated range: [0.76$, 2.07$]
Financial Metrics affecting the BCTX estimates:
- Negative: Non-GAAP EPS, $ of -1.17 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -61.30 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.80 <= 3.85
- Negative: Industry earnings per price (median), % of -23.06 <= 1.31
Short-term BCTX quotes
Long-term BCTX plot with estimates
Financial data
| YTD | 2022-07-31 | 2023-07-31 | 2024-07-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.29MM | $23.27MM | $32.81MM |
| Operating Income | $-15.29MM | $-23.27MM | $-32.81MM |
| Non-Operating Income | $-11.55MM | $2.97MM | $28.02MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $8.02MM | $15.34MM | $26.75MM |
| Income(Loss) | $-26.84MM | $-20.30MM | $-4.79MM |
| Profit(Loss) | $-26.84MM | $-20.30MM | $-4.79MM |
| Stockholders Equity | $10.33MM | $-3.78MM | $-2.38MM |
| Inventory | $0.02MM | $0.02MM | $0.00MM |
| Assets | $42.58MM | $27.16MM | $5.87MM |
| Operating Cash Flow | $-12.48MM | $-23.74MM | $-24.13MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.46MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.68MM |
| Financing Cash Flow | $-3.74MM | $3.95MM | $4.42MM |
| Earnings Per Share* | $-0.75 | $-1.30 | $-0.29 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.